Oxford Asset Management’s Organogenesis Holdings ORGO Stock Holding History

Oxford Asset Management’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$89.7K	Buy	37,842 +25,190	+199%	+$87.3K	0.04%	413
2025 Q4	$65.5K	Buy	+12,652	New	+$61.3K	0.02%	464
2024 Q2	–	Sell	-22,631	Closed	-$64.3K	–	386
2024 Q1	$64.3K	Buy	+22,631	New	+$76.9K	0.07%	242
2018 Q4	–	Sell	-1,538,000	Closed	-$15.6M	–	1996
2018 Q3	$15.6M	Buy	1,538,000 +538,000	+54%	+$5.43M	0.33%	29
2018 Q2	$10M	Buy	+1,000,000	New	+$10M	0.19%	96

Other funds holding ORGO

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Oxford Asset Management's ORGO Position: Q1 2026 in Review

Oxford Asset Management increased its Organogenesis Holdings (ORGO) stake by 199% in Q1 2026, buying an estimated $87.3K and bringing the position to 37,842 shares worth $89.7K. The position accounts for 0.04% of the portfolio, ranked #413.

Oxford Asset Management first reported a position in ORGO in Q2 2018 and has held it in 5 quarters since. The position peaked at $15.6M in Q3 2018. 121 funds tracked by Wall St. Rank hold ORGO as of Q1 2026.

Oxford Asset Management held 37,842 shares of Organogenesis Holdings worth $89.7K as of Q1 2026.
Oxford Asset Management bought 25,190 Organogenesis Holdings shares in Q1 2026, an estimated $87.3K.
Organogenesis Holdings made up 0.04% of Oxford Asset Management's portfolio in Q1 2026, its #413 holding.
Oxford Asset Management first reported a position in Organogenesis Holdings in Q2 2018 and has held it in 5 quarters since.
Oxford Asset Management's Organogenesis Holdings position peaked at $15.6M in Q3 2018.
121 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2026.

Based on Oxford Asset Management's 13F filing for Q1 2026, filed 15 May 2026.